SEATTLE GENETICS INC (76) | Intellectual Property (2)

Browse by Subcategory

License Agreements (2 contracts)

Recent Contracts

License Agreement dated as of August 8, 2021 between RemeGen Co., Ltd. and Seagen Inc (Filed With SEC on September 21, 2021)
Amendment No. 1 to License Agreement dated April 23, 2020 between Cascadian Therapeutics, Inc. and Array BioPharma, Inc (Filed With SEC on July 31, 2020)